Recent Updates
Recently added Catalysts
QDEL Positive Sentiment

QuidelOrtho Launches Certified Analyzer Program QuidelOrtho Corporation has launched a Certified Analyzer Program, an innovative initiative designed to expand access to high-quality diagnostic...

Wednesday, August 13, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: QuidelOrtho Corporation has introduced a Certified Analyzer Program aimed at enhancing access to high-quality diagnostic testing in underserved U.S. communities. This initiative is specifically designed for small hospitals and clinics, providing certified VITROS™ analyzers that ensure reliable results at a reduced cost. The program is expected to significantly benefit rural healthcare facilities.
Price reaction · baseline $25.19 (2025-08-12 close) · hit after-hours · clean, no other QDEL news in the window
day 0 close · peak
+7.5%
day 1
+3%
day 3
+2.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Launch of the Certified Analyzer Program expands testing access.
  • Targets underserved U.S. communities for improved healthcare.
  • Offers reliable and cost-effective diagnostic solutions.

Full Press Release Details

Initiative to expand testing access to underserved U.S. communities
SAN DIEGO , Aug. 13, 2025 /PRNewswire/ -- QuidelOrtho Corporation has launched a Certified Analyzer Program, an innovative initiative designed to expand access to high-quality diagnostic testing in rural and community hospitals across the United States . Tailored for clinics, physician office labs and small hospitals with fewer than 100 beds, the program offers certified VITROS™ analyzers that deliver proven reliability and quality results, with award-winning service, at a fraction of the cost.

Frequently Asked Questions

What is the purpose of the Certified Analyzer Program?

The program aims to expand access to high-quality diagnostic testing in underserved U.S. communities.

Who can benefit from the Certified Analyzer Program?

Clinics, physician office labs, and small hospitals with fewer than 100 beds can benefit.

What type of analyzers does the program offer?

The program offers certified VITROS™ analyzers known for their reliability and quality results.

How does the program impact healthcare costs?

It provides award-winning service and quality results at a fraction of the cost.

ShareAdd on Google
Tags: QDEL Viatris Investor Conferences Healthcare QuidelOrtho diagnostic testing VITROS analyzers healthcare access rural hospitals
Last updated: Aug 13, 2025

Biotech snapshot

Cash runway
$123M liquidity · $7M/mo burn
~17 mo
Low dilution risk